Precision Medicine Collaboration to Increase Options for Cancer Patients

Baylor Research Institute (BRI) at Dallas and the Translational Genomics Research Institute (TGen) in Phoenix, Ariz., today announce an agreement that will focus on accelerating early detection and treatments for patients with a broad range of cancers.

BRI and TGen will offer liquid biopsies, perform gene sequencing, conduct one-of-a-kind clinical trials and create personalized vaccines to enhance patient care throughout the health care system.